Distinguished in Brain Tumor

Xuejun L. Li

Jianshe Road, 
Xinxiang, CN 
Distinguished in Brain Tumor
Jianshe Road, 
Xinxiang, CN 
OverviewLocationsClinical Research

Overview

Xuejun Li practices in Xinxiang, China. Li is rated as a Distinguished expert by MediFind in the treatment of Brain Tumor. Their top areas of expertise are Chronic Erosive Gastritis, Brain Tumor, Glioma, Thyroidectomy, and Pancreaticoduodenectomy.

Their clinical research consists of co-authoring 450 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 78 articles in the study of Brain Tumor.

Locations

Jianshe Road, Xinxiang, 453007, China
Other Locations
No.87 Xiangya Road, Changsha, China
No. 22 Qixiangtai Road, Tianjin, 300070, China
No. 87, Xiangya Road, Changsha, 410008, China
172 Tongzipo Road, Changsha, 410013, China
1Department Of Radiology, No. 87 Xiangya Road, Changsha, 410008, China
No. 139 Middle Renmin Road, Changsha, 410011, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

EMBER-3: A Phase 3, Randomized, Open-Label Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Patients With Estrogen Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With Endocrine Therapy
EMBER-3: A Phase 3, Randomized, Open-Label Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Patients With Estrogen Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With Endocrine Therapy
Enrollment Status: Active_not_recruiting
Publish Date: July 11, 2025
Intervention Type: Drug
Study Drugs: Imlunestrant, Exemestane, Fulvestrant, Abemaciclib
Study Phase: Phase 3

448 Total Publications

Constructing and Visualizing Models using Mime-based Machine-learning Framework.
Constructing and Visualizing Models using Mime-based Machine-learning Framework.
Journal: Journal of visualized experiments : JoVE
Published: August 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Li's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 58 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile